Journal articleAnn Surg · May 1, 2022
OBJECTIVE: The objective of this study was to examine early lung transplant outcomes following EVLP using a large national transplant registry. SUMMARY OF BACKGROUND DATA: Lung transplantation in the United States continues to be constrained by a limited s ...
Full textLink to itemCite
Journal articleJ Thorac Cardiovasc Surg · March 2022
OBJECTIVE: A small but growing proportion of lung transplant recipients survive longer than a decade post-transplant. The aim of this study was to identify factors associated with survival beyond a decade after lung transplant. METHODS: We queried the Unit ...
Full textLink to itemCite
Journal articleSemin Thorac Cardiovasc Surg · 2022
Lung transplantation is the only treatment for end-stage lung disease; however, donor organ shortage and intense immunosuppression limit its broad clinical impact. Bioengineering of lungs with patient-derived cells could overcome these problems. We created ...
Full textLink to itemCite
Journal articleTech Coloproctol · June 2019
BACKGROUND: Due to conflicting study results on the effect of laterality on overall survival in primary colon cancers, we sought to examine the impact of left compared to right-sided primary tumors on overall survival for stage I-III colon cancer using the ...
Full textLink to itemCite
Journal articleAnn Thorac Surg · November 2018
BACKGROUND: Lobar resection is the gold standard therapy for medically fit patients with stage I non-small cell lung cancer (NSCLC). However, considerable variability exists in the use of surgical therapy. This study tested the hypothesis that center-based ...
Full textLink to itemCite